Passenger Load Factor Definition & Meaning | Transportation Term | CSIMarket
CSI Market
Sign In | Register

Glossary

Passenger Load Factor

Transportation Term

Passenger Load Factor (PLF) is a metric used in the transportation industry to measure the average percentage of seats or capacity that is occupied by passengers on a flight, train, bus, or other mode of transportation. It is calculated by dividing the total number of passengers on a particular trip or route by the total available seating or capacity.

The PLF is an important measure of efficiency for transportation providers, as it has a significant impact on profitability and revenue. Higher PLFs indicate that the provider is filling more seats or capacity, which means that they are maximizing the use of their assets and reducing the overall cost per passenger. On the other hand, lower PLFs may indicate that a provider is experiencing operational inefficiencies or low demand for their services.

Transportation providers use PLF data to make decisions about pricing, scheduling, and fleet management. They may offer promotional fares to fill seats during times of low demand or adjust schedules to coincide with peak travel periods. Airlines, for example, may deploy smaller aircraft with higher frequency during off-peak periods to maintain higher PLFs. Transportation providers may also use PLF data to determine which routes or services are most profitable and to make decisions about expanding or reducing capacity based on demand.

Overall, Passenger Load Factor is an important metric that allows transportation providers to optimize their operations, increase efficiency, and maximize profits.




Airline Industry

More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P